Division of Gastroenterology, Hepatology and Nutrition

Evaluation of Infliximab Levels

Principal Investigator: Naamah Zitomersky, MD

Department: Gastroenterology

Protocol Title: The Role of Infliximab Levels and Antibodies to Infliximab as Determinants of Clinical Remission and Loss of Response in Pediatric Inflammatory Bowel DIsease

Protocol Status: Open for Recruitment

Trial Description: The purpose of this study is to understand how infliximab and HACA antibody levels affect both remission rates and loss of response in patients with inflammatory bowel disease who have ever received this treatment.

Recruitment Information: Patients diagnosed with inflammatory bowel disease who are currently taking infliximab or who have taken infliximab in the past.

Recruitment Contact Name: Benjamin Atkinson

Recruitment Contact Phone: (856) 218-4979

Recruitment Contact Email: benjamin.atkinson@childrens.harvard.edu